| Disruption of the GH receptor gene in adult mice increases maximal lifespan in females RK Junnila, S Duran-Ortiz, O Suer, EG Sustarsic, DE Berryman, EO List, ... Endocrinology 157 (12), 4502-4513, 2016 | 73 | 2016 |
| Adipocyte-specific GH receptor–null (AdGHRKO) mice have enhanced insulin sensitivity with reduced liver triglycerides EO List, DE Berryman, M Buchman, C Parker, K Funk, S Bell, ... Endocrinology 160 (1), 68-80, 2019 | 45 | 2019 |
| Male bovine GH transgenic mice have decreased adiposity with an adipose depot-specific increase in immune cell populations F Benencia, S Harshman, S Duran-Ortiz, ER Lubbers, EO List, ... Endocrinology 156 (5), 1794-1803, 2015 | 43 | 2015 |
| GH knockout mice have increased subcutaneous adipose tissue with decreased fibrosis and enhanced insulin sensitivity EO List, DE Berryman, M Buchman, EA Jensen, K Funk, S Duran-Ortiz, ... Endocrinology 160 (7), 1743-1756, 2019 | 42 | 2019 |
| Growth hormone receptor gene disruption in mature‐adult mice improves male insulin sensitivity and extends female lifespan S Duran‐Ortiz, EO List, Y Ikeno, J Young, R Basu, S Bell, T McHugh, ... Aging cell 20 (12), e13506, 2021 | 33 | 2021 |
| Increased fibrosis: a novel means by which GH influences white adipose tissue function LA Householder, R Comisford, S Duran-Ortiz, K Lee, K Troike, C Wilson, ... Growth Hormone & IGF Research 39, 45-53, 2018 | 28 | 2018 |
| Cardiac-specific disruption of GH receptor alters glucose homeostasis while maintaining normal cardiac performance in adult male mice A Jara, X Liu, D Sim, CM Benner, S Duran-Ortiz, Y Qian, EO List, ... Endocrinology 157 (5), 1929-1941, 2016 | 26 | 2016 |
| Growth hormone receptor antagonist transgenic mice are protected from hyperinsulinemia and glucose intolerance despite obesity when placed on a HF diet T Yang, LA Householder, ER Lubbers, EO List, K Troike, C Vesel, ... Endocrinology 156 (2), 555-564, 2015 | 23 | 2015 |
| Mice with gene alterations in the GH and IGF family Y Qian, DE Berryman, R Basu, EO List, S Okada, JA Young, EA Jensen, ... Pituitary, 1-51, 2022 | 22 | 2022 |
| Growth hormone upregulates melanocyte-inducing transcription factor expression and activity via JAK2-STAT5 and SRC signaling in GH receptor-positive human melanoma R Basu, P Kulkarni, Y Qian, C Walsh, P Arora, E Davis, S Duran-Ortiz, ... Cancers 11 (9), 1352, 2019 | 22 | 2019 |
| Characterization of an intestine-specific GH receptor knockout (IntGHRKO) mouse JA Young, EA Jensen, A Stevens, S Duran-Ortiz, EO List, DE Berryman, ... Growth Hormone & IGF Research 46, 5-15, 2019 | 20 | 2019 |
| Disruption of the GH receptor gene in adult mice and in insulin sensitive tissues S Duran-Ortiz, V Noboa, JJ Kopchick Growth Hormone & IGF Research 38, 3-7, 2018 | 19 | 2018 |
| Extending lifespan by modulating the growth hormone/insulin-like growth factor-1 axis: coming of age S Duran-Ortiz, EO List, R Basu, JJ Kopchick Pituitary 24 (3), 438-456, 2021 | 18 | 2021 |
| Effects of tissue-specific GH receptor knockouts in mice EO List, S Duran-Ortiz, JJ Kopchick Molecular and Cellular Endocrinology 515, 110919, 2020 | 18 | 2020 |
| The impact of growth hormone on proteomic profiles: a review of mouse and adult human studies S Duran-Ortiz, AL Brittain, JJ Kopchick Clinical Proteomics 14, 1-22, 2017 | 17 | 2017 |
| Mouse models of growth hormone deficiency EO List, R Basu, S Duran-Ortiz, J Krejsa, EA Jensen Reviews in Endocrine and Metabolic Disorders 22 (1), 3-16, 2021 | 12 | 2021 |
| Growth hormone upregulates mediators of melanoma drug efflux and epithelial-to-mesenchymal transition in vitro and in vivo Y Qian, R Basu, SC Mathes, NA Arnett, S Duran-Ortiz, KR Funk, ... Cancers 12 (12), 3640, 2020 | 11 | 2020 |
| The effects of 20-kDa human placental GH in male and female GH-deficient mice: an improved human GH? EO List, DE Berryman, R Basu, M Buchman, K Funk, P Kulkarni, ... Endocrinology 161 (8), bqaa097, 2020 | 11 | 2020 |
| Standardizing protocols dealing with growth hormone receptor gene disruption in mice using the Cre-lox system S Duran-Ortiz, S Bell, JJ Kopchick Growth Hormone & IGF Research 42, 52-57, 2018 | 9 | 2018 |
| Growth hormone receptor antagonism downregulates ATP-binding cassette transporters contributing to improved drug efficacy against melanoma and hepatocarcinoma in vivo R Basu, Y Qian, S Mathes, J Terry, N Arnett, T Riddell, A Stevens, K Funk, ... Frontiers in Oncology 12, 936145, 2022 | 8 | 2022 |
Edward ListOhio UniversityVerifierad e-postadress på ohio.edu
